Targeting transcriptional co-activators YAP1/TAZ in fusion-positive rhabdomyosarcoma demonstrates a novel strategy in ablating fusion-driven sarcoma transcriptional programing
Conferences
Pecoraro, AF; Rashid, T; Burgess, BA; Linardic, CM; Deel, MD
Published in: CANCER RESEARCH
June 15, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
June 15, 2022
Volume
82
Issue
12
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pecoraro, A. F., Rashid, T., Burgess, B. A., Linardic, C. M., & Deel, M. D. (2022). Targeting transcriptional co-activators YAP1/TAZ in fusion-positive rhabdomyosarcoma demonstrates a novel strategy in ablating fusion-driven sarcoma transcriptional programing. In CANCER RESEARCH (Vol. 82).
Pecoraro, Adam F., Tooba Rashid, Breanne A. Burgess, Corinne M. Linardic, and Michael D. Deel. “Targeting transcriptional co-activators YAP1/TAZ in fusion-positive rhabdomyosarcoma demonstrates a novel strategy in ablating fusion-driven sarcoma transcriptional programing.” In CANCER RESEARCH, Vol. 82, 2022.
Pecoraro AF, Rashid T, Burgess BA, Linardic CM, Deel MD. Targeting transcriptional co-activators YAP1/TAZ in fusion-positive rhabdomyosarcoma demonstrates a novel strategy in ablating fusion-driven sarcoma transcriptional programing. In: CANCER RESEARCH. 2022.
Pecoraro, Adam F., et al. “Targeting transcriptional co-activators YAP1/TAZ in fusion-positive rhabdomyosarcoma demonstrates a novel strategy in ablating fusion-driven sarcoma transcriptional programing.” CANCER RESEARCH, vol. 82, no. 12, 2022.
Pecoraro AF, Rashid T, Burgess BA, Linardic CM, Deel MD. Targeting transcriptional co-activators YAP1/TAZ in fusion-positive rhabdomyosarcoma demonstrates a novel strategy in ablating fusion-driven sarcoma transcriptional programing. CANCER RESEARCH. 2022.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
June 15, 2022
Volume
82
Issue
12
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology